Researchers found that of the patients who underwent capsule endoscopy in their study, 13.6 percent took NSAIDs or aspirin but did not disclose that they were using those medications. Small bowel inflammation was found to be common among these patients and could be mistaken for Crohn’s disease, highlighting the importance of clear medication history for accurate image interpretation.
Read the article about capsule endoscopy.
Read other coverage about capsule endoscopy:
– Remote-Controlled Capsule Endoscopy Safe and Effective for Screening
– 5 Things to Know About the Endoscopy Devices Market
– 6 Observations on the U.S. Market for GI Endoscopy Devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.